Your browser doesn't support javascript.
loading
Immunological changes and prevention of disease progression through elotuzumab therapy in refractory IgG4-related sclerosing mesenteritis.
Comdühr, Sara; Dübbers, Alexander; Tharun, Lars; Graßhoff, Hanna; Stone, John; Pitann, Silke; Riemekasten, Gabriela; Lamprecht, Peter.
  • Comdühr S; Department of Rheumatology and Clinical Immunology, University of Lübeck.
  • Dübbers A; Department of Rheumatology and Clinical Immunology, University of Lübeck.
  • Tharun L; Institute for Pathology, University Medical Center of Schleswig-Holstein-Campus Lübeck, Lübeck, Germany.
  • Graßhoff H; Department of Rheumatology and Clinical Immunology, University of Lübeck.
  • Stone J; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Pitann S; Department of Rheumatology and Clinical Immunology, University of Lübeck.
  • Riemekasten G; Department of Rheumatology and Clinical Immunology, University of Lübeck.
  • Lamprecht P; Department of Rheumatology and Clinical Immunology, University of Lübeck.
Rheumatology (Oxford) ; 61(11): e334-e336, 2022 11 02.
Article en En | MEDLINE | ID: mdl-35595249
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Paniculitis Peritoneal Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Paniculitis Peritoneal Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article